Deutsche Bank’s Haemonetics HAE Stock Holding History

Deutsche Bank’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-53,200	Closed	-$2.59M	–	3665
2025 Q3	$2.59M	Buy	+53,200	New	+$3.29M	﹤0.01%	1629
2025 Q1	–	Sell	-14,000	Closed	-$1.09M	–	3612
2024 Q4	$1.09M	Sell	14,000 -6,000	-30%	-$482K	﹤0.01%	2191
2024 Q3	$1.61M	Buy	20,000 +600	+3%	+$48.5K	﹤0.01%	1885
2024 Q2	$1.6M	Sell	19,400 -41,700	-68%	-$3.67M	﹤0.01%	1745
2024 Q1	$5.21M	Buy	61,100 +31,100	+104%	+$2.44M	﹤0.01%	1256
2023 Q4	$2.57M	Sell	30,000 -30,800	-51%	-$2.66M	﹤0.01%	1547
2023 Q3	$5.45M	Buy	60,800 +60,722	+77,849%	+$5.42M	﹤0.01%	1012
2023 Q2	$6.64K	Buy	+78	New	+$6.59K	﹤0.01%	3682
2022 Q2	–	Sell	-64	Closed	-$4K	–	4203
2022 Q1	$4K	Sell	64 -36	-36%	-$1.96K	﹤0.01%	4170
2021 Q4	$5K	Buy	100 +81	+426%	+$4.93K	﹤0.01%	4204
2021 Q3	$1K	Buy	+19	New	+$1.2K	﹤0.01%	4370

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deutsche Bank's HAE Position: Q1 2026 in Review

Deutsche Bank reduced its Haemonetics (HAE) stake by 11% in Q1 2026, selling an estimated $2.79M and leaving 358,882 shares worth $20.2M. The position accounts for 0.01% of the portfolio, ranked #846.

Deutsche Bank first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $148M in Q3 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Deutsche Bank held 358,882 shares of Haemonetics worth $20.2M as of Q1 2026.
Deutsche Bank sold 42,876 Haemonetics shares in Q1 2026, an estimated $2.79M.
Haemonetics made up 0.01% of Deutsche Bank's portfolio in Q1 2026, its #846 holding.
Deutsche Bank first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
Deutsche Bank's Haemonetics position peaked at $148M in Q3 2018.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.